A jury found that Abbott Laboratories' specialized formula for premature infants caused an Illinois girl to develop a dangerous bowel disease, ordering the healthcare company to pay $495 million in d
A jury on Friday found that Abbott Laboratories' specialized formula for premature infants caused an Illinois girl to develop a dangerous bowel disease, ordering the healthcare company to pay $95 mill
Abbott (NYSE: ABT) recently reported its Q2 results, with revenues and earnings exceeding our expectations. The company reported revenue of $10.4 billion and earnings of $1.14 on a per-share and adjus
Healthcare stocks are generally good bets, thanks to a rapidly growing population of older adults in the U.S. and other developed economies. Abbott Laboratories is growing sales at a high-single-digit
Abbott's diverse business and low beta value make it one of the safest dividend stocks you can own. Home Depot doesn't expect much growth this year, but that likely won't remain a long-term problem.
Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
These blue-chip companies have demonstrated strong dividend growth rates ranging from 7.69% to 15.8% annually over the past five years. The list includes diverse sectors such as retail, healthcare, te

7 Safe Stocks to Buy for Volatility Insurance

03:16pm, Thursday, 18'th Jul 2024
The concept of safe stocks arguably couldn't be timelier. Recently, the technology sector encountered significant turmoil, with many experts questioning the sustained success of artificial intelligenc
Shares of Abbott Laboratories (ABT) declined in intraday trading Thursday as the healthcare products maker's sales of COVID-19 tests slumped with the pandemic ending.
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Thursday.
Abbott Laboratories will use a mix of TV advertisements and guerilla marketing as well as seek to personalize health data to tap people without diabetes for the U.S. launch of its glucose monitoring d
Abbott Laboratories (NYSE: ABT) faced a 3.0% decline in stock price this morning despite reporting a strong second quarter and raising its full-year guidance. Meanwhile, CEO Robert B.
Abbott Laboratories (NYSE:ABT ) Q2 2024 Earnings Conference Call July 18, 2024 9:00 AM ET Company Participants Robert Ford - Chief Executive Officer Phil Boudreau - Executive Vice President, Finance,

Jobless Claims Increased More Than Expected

12:06pm, Thursday, 18'th Jul 2024
Another Thursday morning, another Weekly Jobless Claims report. On an Initial Claims basis, we jump back up to where we were two weeks ago, to +243K new claims — a near-term high going back to Augus
Abbott (ABT) delivers a strong underlying base business performance in the second quarter of 2024.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE